• Tue, May 24, 2022
Salveen Richter Maintained (ALLO) at Hold with Decreased Target to $9 on, May 24th, 2022
Salveen Richter of Goldman Sachs, Maintained "Allogene Therapeutics, Inc." (ALLO) at Hold with Decreased Target from $12 to $9 on, May 24th, 2022.
Salveen has made no other calls on ALLO in the last 4 months.
There is 1 other peer that has a rating on ALLO. Out of the 1 peers that are also analyzing ALLO, 0 agree with Salveen's Rating of Hold.
This is the rating of the analyst that currently disagrees with Salveen
- Dane Leone of "Raymond James" Maintained at Buy with Decreased Target to $13 on, Thursday, May 5th, 2022
Like: 👍
